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Abstract Objective: To assess health care providers (HCP)
knowledge and practices regarding folic acid (FA) use
for neural tube defect (NTD) prevention. Methods:T w o
identical surveys were conducted among 611 obstetri-
cians/gynecologists (OB/GYNs) and family/general physi-
cians (FAM/GENs) (2002), and 500 physician assistants
(PAs), nurse practitioners (NPs), certiﬁed nurse midwives
(CNMs), and registered nurses (2003) to ascertain knowl-
edge and practices regarding FA. For analysis, T-tests, uni-
variate and multivariate logistic regression modeling were
used. Results: Universally, providers knew that FA prevents
birth defects. Over 88% knew when a woman should start
taking folic acid for the prevention of NTDs; and over 85%
knew FA supplementation beyond what is available in the
diet is necessary. However, only half knew that 50% of
all pregnancies in the United States are unplanned. Women
heardinformationaboutmultivitaminsorFAmostoftendur-
ing well woman visits in obstetrical/gynecology (ob/gyn)
practice settings (65%), and about 50% of the time dur-
ing well woman visits in family/general (fam/gen) practice
settings and 50% of the time at gynecology visits (both set-
tings). Among all providers, 42% did not know the correct
FA dosage (400 µg daily). HCPs taking multivitamins were
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more than twice as likely to recommend multivitamins to
their patients (Odds Ratio [OR] 2.27 95%, Conﬁdence In-
terval [CI] 1.75–2.94). HCPs with lower income clients (OR
1.49, CI 1.22–1.81) and HCPs with practices having more
than 10% minorities (OR 1.46, CI 1.11–1.92) were more
likely to recommend supplements. NPs in ob/gyn settings
were most likely and FAM/GENs were least likely to recom-
mend supplements (OR 3.06, CL 1.36–6.90 and OR 0.64,
CL 0.45–0.90 respectively). Conclusions: Knowledge about
birth defects and the necessity of supplemental FA was high.
Increasing knowledge about unintended pregnancy rates and
correct dosages of FA is needed. The strongest predictor for
recommending the use of FA supplements was whether the
provider took a multivitamin.
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Introduction
Birthdefectscontinuetobetheleadingcauseofinfantmorta-
lity in the United States [1], and those of the nervous system,
including neural tube defects (NTDs), are the third leading
type of birth defect [2]. NTDs are serious birth defects of the
brain(anencephaly)andspine(spinabiﬁda),affectingappro-
ximately3000pregnancieseachyearintheUnitedStates[3].
Studies show that 50–70% of these birth defects can be pre-
vented if a woman consumes adequate folic acid (FA) daily
before conception and throughout the ﬁrst trimester of preg-
nancy[4,5].TheU.S.PublicHealthService(USPHS)(1992)
and Institute of Medicine (IOM) (1998) issued separate rec-
ommendations that all women of childbearing age consume
400µgofFAdailyforthepreventionofNTDs[5,6].Women
can obtain adequate amounts of FA by taking a folic acid
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supplement, taking a multivitamin containing folic acid, or
by eating cereal grain products fortiﬁed with 100% of the
RDA of folic acid.
In 1998, the U.S. Food and Drug Administration required
mandatoryfortiﬁcationofenrichedcerealgrainswith140µg
of FA per 100 g of cereal grain product in an effort to reduce
the occurrence of NTDs [7]. It was estimated that FA fortiﬁ-
cation at this level would provide about 0.1 mg of additional
folic acid in the average diet. Recent evidence from the liter-
aturesuggeststhatfortiﬁcationhasinfactdoubledthisinitial
projection [8]. Fortiﬁcation of cereal grain products has re-
sulted in a 27% reduction in NTDs in the United States [3],
which is relatively consistent with the observed population’s
increase of folic acid by 0.2 mg/d [9]. While fortiﬁcation has
made a signiﬁcant contribution in preventing NTDs, most
women in the U.S. still do not get enough FA from fortiﬁca-
tion alone. In a recent study examining serum folate levels
of women of childbearing age post fortiﬁcation, “less than
10% of women achieved a red blood cell folate level that
is associated with a signiﬁcant decrease of NTDs” through
diet alone [10]. Therefore, it is still necessary for women of
childbearing age to consume vitamins containing FA to get
the daily recommended amount of FA (400 µg).
Since 1995, the March of Dimes (MoD) and the Gallup
Organization have conducted an annual national survey
among women of childbearing age regarding their aware-
ness, knowledge, and consumption of FA. Early results in-
dicated a lack of awareness about FA among women of
childbearing age. In 1999, in response to these results, the
MoD,theCentersforDiseaseControlandPrevention(CDC),
and the National Council on Folic Acid (NCFA) began a
concerted effort to increase FA awareness through educa-
tion campaigns targeting women and health care providers
(HCPs). Based on the MoD survey, FA awareness in women
of childbearing age has risen from 52% in 1995 to 77% in
2004 [11]. Lagging behind the increase in awareness, daily
consumptionofamultivitamincontainingFAincreasedonly
slightly from 32% in 1995 to 40% in 2004 [11, 12]. When
asked what types of things would encourage them to take a
multivitamin daily, unprompted, 42% of women who were
aware of, but not consuming, FA said they would take a mul-
tivitamin if advised to do so by an HCP [11]. Additionally,
in the 2004 HealthStyles Survey, 91% of women 18 through
45 years of age agreed or strongly agreed that they would
take a multivitamin daily to prevent birth defects during fu-
ture pregnancies if their doctor encouraged them to do so
(unpublished data) [13].
Two recent studies examined HCP practices regarding FA
intheUnitedStates[14,15].Whileprovidersweregenerally
aware of folic acid’s role in NTD prevention, only half of
providers surveyed in both studies discussed folic acid on a
regular basis with their patients of childbearing age.
In 2001, the MoD, in partnership with the CDC, initiated
this project to examine HCP practices regarding FA. The
objectives of this research are to:
 Assess HCP knowledge of FA recommendations, includ-
ing dosage and timing for prevention of NTDs, among
different provider types: obstetricians/gynecologists
(OB/GYNs), family/general physicians (FAM/GENs),
nurse practitioners (NPs), certiﬁed nurse midwives
(CNMs), physician assistants (PAs), and registered nurses
(RNs).
 Assess current practices among HCPs with respect to rec-
ommending FA to women of childbearing age.
 Identify the best means of supporting HCP efforts to pro-
mote FA consumption in female patients of childbearing
age.
Methods
Random sample telephone surveys lasting an average of
12–18 minutes in length, were conducted in 2002 and
2003 among HCPs working in either obstetrical/gynecology
(ob/gyn) practice settings or family/general (fam/gen) prac-
tice settings. These practice settings were selected because
they represent the settings where the highest proportion
of women of childbearing age receive care on a regular
basis.
Geographic quotas were established to ensure a represen-
tationofrespondentsproportionaltotheactualdistributionof
ofﬁce-based providers nationwide. Providers were identiﬁed
through random sampling lists purchased from American
Medical Information Inc., a division of InfoUSA. To iden-
tify sufﬁcient representation of providers based in federally
qualiﬁed health centers, a list of centers from the Health
Resources and Services Administration’s Bureau of Primary
Health Care website (http://ask.hrsa.gov/pc/) was added to
the sampling frame.
The identities of respondents were not revealed. This re-
search met the requirements of Title 45 CFR part 46 for the
protection of human subjects.
To encourage participation, respondents were offered a
$50 honorarium. The identity of the sponsors (CDC and
MoD) was not divulged to respondents. A cover letter from
the research ﬁrm was faxed to participants who requested
additional background information about the survey.
Health care providers were eligible to participate if they
personallysawadultfemalepatientsforofﬁceorclinicvisits,
and worked in ob/gyn, or fam/gen medicine practices.
The surveys were presented as a series of true/false, mul-
tiple choice, and open-ended questions. The survey sought
to determine the level of HCP knowledge regarding the role
of FA in the prevention of NTDs, when HCPs recommended
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Table 1 Provider type and practice setting
Practice setting
Obstetrics/ Family/General
Provider typea Gynecology Medicine
OB/GYN 362 0
FAM/GEN 0 249
PAs 16 38
NPs 55 46
CNMs 200 0
RNs 77 63
Total 710 396
Note. 5 missing provider variables not categorized.
aProvider type abbreviations: OB/GYN—obstetrician/gynecologist;
FAM/GEN—family or general practice physician; PA—physician as-
sistant; NP—nurse practitioner; CNM—certiﬁed nurse midwife; RN—
registered nurse.
FA, and how often HCPs recommended FA to women of
childbearing age.
Data were analyzed using SPSS software (SPSS, 12.0,
SPSS, Inc., 2003, Chicago, IL). T-tests, univariate compar-
isons and multivariate logistic regression modeling of the
data were conducted. All analyses were tested for signiﬁ-
cance at the 95% conﬁdence level (p-value 0.05).
Results
Investigators surveyed 611 physician HCPs in 2002 and 500
nonphysician HCPs in 2003 (Table 1).
In 2002, 2552 physicians were screened as potentially
qualiﬁedrespondents.Ofthese2552physicians,1213(48%)
did not participate in surveys, 366 (14%) requested addi-
tional information but did not schedule an interview, 184
(7%) did not meet practice setting requirements, 142 (6%)
had fax numbers as the primary contact, 19 (1%) were
qualiﬁed refusals and 11 (0.4%) had appointments set but
not kept. The response rate for eligible physicians was
24%.
In 2003, 650 nonphysician HCPs were screened as po-
tentially qualiﬁed respondents. Of these 650 nonphysician
HCPs, 73 (11%) did not participate in surveys and 75 (12%)
were qualiﬁed refusals. The response rate for eligible non-
physician HCPs was 77%.
The majority of physicians were male (77%), younger
than 55 years of age (69%), and in practice over 20 years
(50%). Nonphysician HCPs were typically female (97%)
and younger than 55 years of age (82%); 28% had been
in practice over 20 years. Nonphysician HCPs were two
times more likely than physician HCPs to work with under-
servedpopulations(OddsRatio[OR]1.97,ConﬁdenceInter-
val[CI]1.54–2.53).NonphysicianHCPssawmorewomenof
childbearing age in their practices (67%) than physicans
(52%) (p-value <0.000).
The following results were obtained from a series of
true/false questions.
In general, knowledge that women need a supplemental
source of FA was high (∼85%). Universally, HCPs in both
practice settings (97%) knew correctly that FA can prevent
some birth defects. However, only ∼60% of all providers
knew that most grain products in the United States are forti-
ﬁed with FA. In addition, there were signiﬁcant differences
in response to this question among provider types according
to practice setting, ranging from 71.3% of RNs in ob/gyn
settings to 44.7% of PAs in fam/gen settings (p-value 0.030).
The following data were obtained from multiple choice
questions.Providersinob/gynsettingswerenotmoreknowl-
edgeable than providers in fam/gen settings about when a
woman should start taking FA for the prevention of NTDs
(at least one month prior to conception through the ﬁrst
trimester of pregnancy) (88% vs. 89%, respectively, p-value
0.094).
Becausethemajorityofrespondentsknewthecorrecttim-
ing for a woman to start taking FA, providers were asked to
identify what percentage of pregnancies they thought were
unintended in the United States. Only about half of HCPs
in both settings knew that approximately 50% of all preg-
nancies in the United States are unplanned [16]. The most
knowledgeable group was NPs in ob/gyn settings (58.9%),
and the least knowledgeable group was RNs in ob/gyn set-
tings (35.0%) (p-value 0.002). Providers answering incor-
rectly were more likely to underestimate rather than overes-
timate the unintended pregnancy rate. Although a woman’s
receptiveness to the FA message might increase during a
preconception care visit, HCPs providing prenatal care saw
only a quarter of their pregnant patients for a preconception
care visit.
Over half (58%) of all providers were knowledgeable
about the amount of FA (400 µg) a woman needs daily for
prevention of NTDs. Providers in ob/gyn settings were more
knowledgeable than providers in fam/gen settings. The most
knowledgeable group was CNMs, with 73.4% knowing the
correct daily dosage of FA; the least knowledgeable group
wasFAM/GENphysicians(41.9%)(p-value<0.000).When
asked about the amount of FA a woman with a prior NTD
affected pregnancy should take toprevent therecurrence of a
NTD (4 mg), overall knowledge dropped dramatically, with
only about 30% of all providers knowing the correct dose.
Providers in ob/gyn settings were more knowledgeable than
providers in fam/gen settings, The most knowledgeable
group was OB/GYNs (46%) and the least knowledgeable
were RNs in fam/gen settings (11.1%) (p-value <0.000).
Of critical importance to increasing consumption of FA
among women of childbearing age is whether FA is in-
corporated into preventive health care messages during
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provider/patient encounters. Providers were asked if they al-
ways, usually, sometimes, or never addressed multivitamins
or FA during well-woman examinations. More providers in
ob/gyn settings than in fam/gen settings stated they regularly
(always/usually)addressedmultivitaminsorFAduringwell-
woman visits (65% vs. 50%, respectively). Women were 1.8
times more likely to hear about multivitamins or FA during
encounters in ob/gyn settings than in fam/gen settings (CI
1.42–2.34). The group most likely to talk to patients about
multivitamins and FA was NPs in ob/gyn settings (83.9%);
the least likely were FAM/GEN physicians (45.6%) (p-value
<0.00). Fewer counseling opportunities were taken at other
types of examinations. Women heard the FA message about
half the time from providers in both settings at routine gyne-
cology visits. As expected, the fewest counseling opportuni-
ties taken were at episodic visits in both settings.
Predictors for recommending a multivitamin at a well-
womanvisitweredetermined.Thetypeofproviderandclinic
setting variables were combined as the base variable, with
OB/GYNsasthereferentgroup.Thedependantvariablewas
whether the HCP always or usually recommended a multivi-
tamin during a well-woman visit. Variables examined were
number of weekly visits, provider age, sex, personal vitamin
use, provider’s years in practice, ethnicity of patients, prac-
ticesetting,socioeconomicstatusofpatientbase,patientage,
clinic setting (urban, suburban, or rural) and region of prac-
tice. Clinic setting (urban, suburban, or rural), provider age,
region of practice, provider’s years in practice, number of
weekly visits, and patient age variables were not statistically
signiﬁcant in univariate analysis.
Table2representsthevariablesincludedinthelogisticre-
gression model. In comparison with OB/GYNs, FAM/GEN
physicians were statistically less likely (OR 0.64, CI 0.45–
0.90) to recommend multivitamins, while NPs in ob/gyn
settings were three times more likely (OR 3.06, CI 1.36–
6.90) than their OB/GYN physician counterparts to provide
counsel on multivitamins. While not quite reaching signif-
icance, CNMs were 1.6 times more likely (OR 1.56, CI
0.96–2.53) than OB/GYNs to provide counsel on multivita-
mins. All other groups were not signiﬁcantly different from
OB/GYNs. Interestingly, whether a provider personally took
a multivitamin was one of the strongest predictors of recom-
mending multivitamin use to patients. Providers who regu-
larly took a multivitamin were 2.3 times more likely (OR
2.27, CI 1.75–2.94) to recommend multivitamin use to their
patients. Additional predictors of recommending multivita-
min use were whether a provider stated that his or her prac-
tice’s patient base was classiﬁed as poverty or low income,
or if the practice consisted of at least 10% minorities. Being
a female provider was also correlated with recommending
multivitamin use to women of child-bearing age.
Approximately three-quarters of all respondents had seen
information about FA in the last year. Unprompted, both
Table 2 Factors associated with recommending multivitamins at
well-woman visits included in multivariate logistic regression model
Variables Odds ratio
95% Conﬁdence
interval
Provider Type
OB/GYN Referent Referent
FAM/GEN 0.64 0.45–0.90∗
CNM 1.56 0.96–2.53
NP in ob/gyn setting 3.06 1.36–6.90∗
PA in ob/gyn setting 0.89 0.30–2.66
RN in ob/gyn setting 0.80 0.45–1.43
NP in fam prac setting 0.90 0.45–1.79
PA in fam prac setting 0.63 0.30–1.34
RN in fam prac setting 0.92 0.48–1.77
Gender
Male Referent Referent
Female 1.62 1.11–2.36∗
Provider takes a multivitamin
No Referent Referent
Yes 2.27 1.75–2.94∗
SES of patient base
Middle or high income Referent Referent
Poverty or low income 1.49 1.22–1.81∗
Minorities
<10% minorities Referent Referent
>10% minorities 1.46 1.11–1.92∗
∗Denotes statistical signiﬁcance.
physician and nonphysician HCPs reported that the organi-
zation most likely to have provided that information was
the MoD (25% and 46% respectively). Medical journals
were identiﬁed most frequently as a way to effectively reach
providers with information about FA (66% physicians, 62%
nonphysicians). Nonphysician providers reported the Inter-
net as the second most effective way (15%), and physi-
cians reported either medical associations or conferences
as the second most effective way to reach them with in-
formation about FA (12 and 11%, respectively). Providers
identiﬁed up to two types of resources they would like to
have to promote FA intake among patients. Printed materials
were the most popular type of resource requested by HCPs.
Sixty percent (60%) of physician and 69% of nonphysician
providers requested brochures to distribute to their patients.
Additional print resource requests included charts and ar-
ticles. Free vitamins for patients were also requested (data
not shown).
Discussion
These ﬁndings suggest that physician and nonphysician
providers in both ob/gyn and fam/gen settings know that
FA can prevent NTDs and that FA must be used from at least
one month before pregnancy and continued through the ﬁrst
trimester. Consistent with other studies, provider knowledge
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of FA did not necessarily translate into counseling patients
about its beneﬁts [15 ,17].
Providers in ob/gyn settings were almost twice as likely
as providers in fam/gen settings to regularly address multi-
vitamin or FA use during well-woman visits. Although NPs
and CNMs in ob/gyn settings were most likely to regularly
address multivitamin or FA use with their patients, these
providers might not have as many opportunities to coun-
sel women who are not contemplating pregnancy. Because
providers in fam/gen settings provide routine care to large
numbers of women of childbearing age, they play an im-
portant role in counseling women about FA consumption.
Healthy People 2010 calls for an increase in the number of
pregnancies begun with an optimum FA level. Providers in
fam/gen settings are critical participants in the process of
making the goals of Healthy People 2010 a reality [18, 19].
GreateropportunitiesforpromotingFAexistthroughchang-
ing provider practice behavior in fam/gen settings. It also
appears that well-woman examinations in fam/gen settings
and routine gynecology visits in both settings are important
yet underutilized opportunities for HCPs to counsel women
about multivitamin and FA use. The episodic visit was the
least utilized, but with all the competing priorities at these
types of encounters, counseling of multivitamins might not
take precedence over other topics to be covered within lim-
ited timeframes.
Providers in ob/gyn settings were more likely than
providers in fam/gen settings to know the correct amount of
FA needed for NTD prevention (400 µg daily). Less than a
third of all providers knew the correct amount of FA needed
for the prevention of recurrence (4 mg). Because women
with a previous NTD-affected pregnancy are at an increased
risk for another NTD-affected pregnancy, it is important for
all providers to know the correct amount of FA needed for
recurrence prevention.
Onlyabouthalfofprovidersinbothpracticesettingsknew
that approximately 50% of pregnancies in the United States
areunplanned.Withoutscreeningtheirfemalepatientsabout
pregnancy intention, perhaps providers should be recom-
mending FA to all women of childbearing age.
Oneofthemostinterestingﬁndingswasthattheproviders
surveyed “practice what they preach.” Providers who reg-
ularly took multivitamins were more likely to recom-
mend multivitamins to their patients. Studies looking at
other health behaviors have shown this as well [20, 21].
Thus, including personal health behavior change messages
in HCP outreach about multivitamins and FA might be
advantageous.
In this dataset, a practice that served predominantly
poverty or low income (low socioeconomic status) clien-
tele or a practice consisting of at least 10% minorities pre-
dictedrecommendingamultivitamin.Amongminoritiesand
women with low socio-economic status, critical gaps in
knowledge and practice on the beneﬁts of periconceptional
folic acid have been documented, especially among Hispan-
ics, who are most vulnerable for NTDs [11, 22–24]. The
ﬁndings in this survey that minorities and women of lower
socio-economic status do appear to be targeted is encourag-
ing, and underscores the importance of preconception care
education programs for healthcare providers serving high-
risk populations.
This study has certain limitations. Physician HCPs had
a low response rate compared to nonphysician HCPs. We
cannot comment on the providers who did not respond to the
survey. Providers answering the survey might differ in
knowledge and practice than non-responding providers. Ad-
ditionally, one provider group surveyed (PAs) had small
numbers. Many of the variables examined were associated
with one another. In the logistic regression modeling, female
sex of the HCP was a signiﬁcant factor in predicting recom-
mending multivitamins to female patients of childbearing
age. This is most likely because the majority of the providers
surveyed in 2003 were women.
Conclusions
While it would be most beneﬁcial for women of child-
bearing age to get adequate folic acid from fortiﬁed foods
alone, alternatives include efforts to educate all childbearing
aged women. Several approaches to educating and promot-
ing folic acid consumption are endorsed by the U.S. Public
HealthService.Theseapproachesincludedirecttoconsumer
marketing, public health awareness activities, health care
provider outreach, and policy strategies. This study exam-
ined just one aspect (HCPs) of the multifaceted approach
needed to increase FA intake among women of childbearing
age. Collaboration between public health and medical care
servicesiscriticalineducatingwomenaboutFAandmultivi-
tamin use as health care providers are trusted professionals.
Mobilizingfolicacidawareness effortstotargetHCPsmight
assist providers with patient preconception care education.
Training providers while in school or residency programs, or
by offering continuing education courses that cover methods
of applied behavior change and health education might be
useful for increasing the numbers of women hearing about
folic acid from their health care provider. Additionally, fur-
ther research on what barriers HCPs experience when pro-
viding preventive care, such as provider time constraints,
self-efﬁcacy, and what their perceptions are on the beneﬁts
of preventive care, is needed. As many preventive behavior
and wellness messages exist, providers are forced to priori-
tize according to the length of and reason for patient visits.
Finding a creative way to make FA counseling a priority is
critical to making the FA message a consistent part of the
patient/health care provider dialogue.
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